Literature DB >> 7127969

Girdlestone arthroplasty for infected total hip arthroplasty.

E S Bittar, W Petty.   

Abstract

Results of a previous study of 21 patients who underwent conversion of infected total hip arthroplasties to Girdlestone resection arthroplasties suggested that Girdlestone resection arthroplasty provides a functionally poor salvage technique and is often painful. The present study was undertaken to assess further the salvage value of Girdlestone arthroplasties for the treatment of infected total hips. Fourteen additional cases were reviewed, summarizing the clinical experience of the past three years. These more recent data support the conclusion that resection arthroplasty provides a poor functional result when used as a salvage procedure following removal of infected total hip components. Of the 14 patients reviewed, only one obtained an acceptable functional result. The initial 21 patients studied were re-reviewed to obtain further follow-up data. The functional results obtained were essentially unchanged and are comparable with those from the series of 14 patients reviewed in this study. In some cases of infected total hip arthroplasty, resection arthroplasty is the best method of treatment available, but the results are often far from ideal. Direct or indirect prothesis exchange is an alternative in some cases. Total hip arthroplasty should not be recommended for the young patient who has one or two joint diseases and no limiting systemic factors, with the expectation that when the total hip fails, it can be converted to a resection arthroplasty and the patient improved as compared with the pre-total hip status. It may be wiser to utilize another procedure, e.g., fusion, resection arthroplasty, or osteotomy, primarily, and then revise to a total hip, if necessary, when the patient is older.

Entities:  

Mesh:

Year:  1982        PMID: 7127969

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  21 in total

1.  An articulating antibiotic spacer controls infection and improves pain and function in a degenerative septic hip.

Authors:  Erin E Fleck; Mark J Spangehl; Venkat R Rapuri; Christopher P Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

2.  Reconstructive surgery of the lower extremity.

Authors:  R J Claridge
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

3.  Long-term results of the Girdlestone hip.

Authors:  R T Müller; K F Schlegel; H Konermann
Journal:  Arch Orthop Trauma Surg       Date:  1989       Impact factor: 3.067

4.  [Replacement of infected total hip prosthesis in two stages].

Authors:  E Lenoble; D Goutallier
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

5.  Prosthetic replacement in secondary Girdlestone arthroplasty has an unpredictable outcome.

Authors:  Markus E Rittmeister; Lilian Manthei; Nils P Hailer
Journal:  Int Orthop       Date:  2005-04-13       Impact factor: 3.075

6.  Accumulation of fatty marrow in the osteonecrotic hip mimicking joint infection.

Authors:  Tae-Young Kim; Sun-Joo Kim; Young-Kyun Lee; Kyung-Hoi Koo
Journal:  Clin Orthop Relat Res       Date:  2011-08-31       Impact factor: 4.176

7.  One stage surgical management of deep infection of total hip arthroplasty.

Authors:  D M Mulcahy; J M O'Byrne; G E Fenelon
Journal:  Ir J Med Sci       Date:  1996 Jan-Mar       Impact factor: 1.568

8.  Structural allograft as an option for treating infected hip arthroplasty with massive bone loss.

Authors:  Paul T H Lee; Robert A Clayton; Oleg A Safir; David J Backstein; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

9.  Total hip arthroplasty for primary septic arthritis of the hip in adults.

Authors:  Chin-En Chen; Jun-Wen Wang; Rei-Jahn Juhn
Journal:  Int Orthop       Date:  2007-05-05       Impact factor: 3.075

10.  Successful salvage of an unstable Girdlestone's excision arthroplasty with a megaprosthesis of the hip.

Authors:  Raju Vaishya; Vipul Vijay; Abhishek Vaish
Journal:  J Clin Orthop Trauma       Date:  2015-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.